Cargando…
Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
BACKGROUND: Coronary heart disease (CHD) has become one of the biggest health problems in the world. Stable angina is a common clinical type of CHD with poor prognosis and high mortality. Although there are various interventions for stable angina, none of them can significantly reduce mortality. Bot...
Autores principales: | Ruan, Xiaofen, Li, Yiping, Sun, Yuanlong, Jia, Meijun, Xu, Xiaowen, Huo, Li, Song, Wei, Yao, Yili, Wang, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287819/ https://www.ncbi.nlm.nih.gov/pubmed/34281600 http://dx.doi.org/10.1186/s13063-021-05448-6 |
Ejemplares similares
-
Suxiao Jiuxin Pill protects cardiomyocytes against mitochondrial injury and alters gene expression during ischemic injury
por: Ruan, Xiaofen, et al.
Publicado: (2017) -
Suxiao Jiuxin Pill Induces Potent Relaxation and Inhibition on Contraction in Human Artery and the Mechanism
por: Bai, Xiao-Yan, et al.
Publicado: (2014) -
Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone
por: Li, Sa, et al.
Publicado: (2023) -
Suxiao Jiuxin Pill alleviates myocardial ischemia–reperfusion injury through the ALKBH5/GSK3β/mTOR pathway
por: Li, Yiping, et al.
Publicado: (2023) -
Efficacy of Suxiao Jiuxin Pill on Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials
por: Ren, Li, et al.
Publicado: (2018)